Diagnosis and treatment of gastrointestinal stromal tumors(GIST) :an analysis of 86 cases

J. Hou, Yuankui Wang, Liang Gao, Zhen-Lue Li
{"title":"Diagnosis and treatment of gastrointestinal stromal tumors(GIST) :an analysis of 86 cases","authors":"J. Hou, Yuankui Wang, Liang Gao, Zhen-Lue Li","doi":"10.3760/CMA.J.ISSN.1673-8799.2016.03.003","DOIUrl":null,"url":null,"abstract":"Objective \nTo analyze the clinical characteristics and treatment of gastrointestinal stromal tumors(GIST). \n \n \nMethods \nThe Clinical data of 86 patients of GIST proved pathologically admitted from July 2000 to September 2015 at Department of surgery, the Second Traditional Medicine Hospital of Luoyang were analyzed retrospectively. \n \n \nResults \nThe tumors originated respectively from the esophagus(n=2),stomach (n=43),duodenum(n=1),intestine(n=21),colon(n=5),rectum(n=2),pelvic cavity(n=6),peritoneum(n=6).Twenty-six cases of gastric and five cases of colon GIST were performed by laparoscopic lumpectomy.Fifty-five cases of GIST were performed by laparotomy.Six of them underwent palliative resection or biopsy because of extensive metastasis.Forty-nine cases were resected completely.There was no operative mortality.Sixty-three cases were followed-up.Recurrence and metastasis in ten patients,and eight of them were abdominal metastasis. \n \n \nConclusion \nSurgical procedures is the first choice for treatment of GIST,imatinib mesylate targeted therapy can improve survival. \n \n \nKey words: \nGastrointestinal stromal tumors; Surgical procedures; Imatinib mesylate","PeriodicalId":64135,"journal":{"name":"中国临床实用医学","volume":"7 1","pages":"7-9"},"PeriodicalIF":0.0000,"publicationDate":"2016-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国临床实用医学","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1673-8799.2016.03.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To analyze the clinical characteristics and treatment of gastrointestinal stromal tumors(GIST). Methods The Clinical data of 86 patients of GIST proved pathologically admitted from July 2000 to September 2015 at Department of surgery, the Second Traditional Medicine Hospital of Luoyang were analyzed retrospectively. Results The tumors originated respectively from the esophagus(n=2),stomach (n=43),duodenum(n=1),intestine(n=21),colon(n=5),rectum(n=2),pelvic cavity(n=6),peritoneum(n=6).Twenty-six cases of gastric and five cases of colon GIST were performed by laparoscopic lumpectomy.Fifty-five cases of GIST were performed by laparotomy.Six of them underwent palliative resection or biopsy because of extensive metastasis.Forty-nine cases were resected completely.There was no operative mortality.Sixty-three cases were followed-up.Recurrence and metastasis in ten patients,and eight of them were abdominal metastasis. Conclusion Surgical procedures is the first choice for treatment of GIST,imatinib mesylate targeted therapy can improve survival. Key words: Gastrointestinal stromal tumors; Surgical procedures; Imatinib mesylate
胃肠道间质瘤86例诊治分析
目的分析胃肠道间质瘤(GIST)的临床特点及治疗方法。方法回顾性分析2000年7月至2015年9月洛阳第二中医医院外科收治的经病理证实的86例GIST患者的临床资料。结果肿瘤分别起源于食道(2例)、胃(43例)、十二指肠(1例)、肠(21例)、结肠(5例)、直肠(2例)、盆腔(6例)、腹膜(6例)。腹腔镜下行胃间质瘤切除术26例,结肠间质瘤切除术5例。经剖腹手术治疗间质瘤55例。其中6例因广泛转移而行姑息性切除或活检。49例完全切除。无手术死亡率。对63例进行了随访。复发转移10例,其中腹部转移8例。结论手术是治疗GIST的首选方法,甲磺酸伊马替尼靶向治疗可提高生存率。关键词:胃肠道间质瘤;外科手术;甲磺酸伊马替尼
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
6167
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信